PIN48 COMPARATIVE COST-EFFICACY ANALYSIS OF DARUNAVIR/R AND OTHER RITONAVIR-BOOSTED PROTEASE INHIBITORS FOR FIRST-LINE TREATMENT OF HIV-I INFECTION IN GERMANY
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75106-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)75106-8/fulltext
Title :
PIN48 COMPARATIVE COST-EFFICACY ANALYSIS OF DARUNAVIR/R AND OTHER RITONAVIR-BOOSTED PROTEASE INHIBITORS FOR FIRST-LINE TREATMENT OF HIV-I INFECTION IN GERMANY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75106-8&doi=10.1016/S1098-3015(10)75106-8
First page :
Section Title :
Open access? :
No
Section Order :
1031